Contact Us
Drug Search Results
More Filters [+]

Triflusal

Alternative Names: triflusal
Latest Update: 2024-01-06
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: PA Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Brazil | Bulgaria | Chile | Dominican Republic | Greece | Hungary | India | Indonesia | Italy | Korea | Lebanon | Malaysia | Mexico | Morocco | Peru | Philippines | Portugal | Romania | South Africa | Spain | Thailand | Ukraine | Uruguay | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: J. Uriach and Company
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Triflusal

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Other|Ischemic Stroke

Phase 2: Depressive Disorder|Obesity|Insulin Resistance

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
Tricross-Basel

P2

Completed

Depressive Disorder

2017-02-21

Tribunal-Basel

P2

Completed

Depressive Disorder

2015-11-01

MAESTRO

P4

Completed

Ischemic Stroke

2014-12-01

NCT01612273

P4

Completed

Other

2013-01-01

Recent News Events

Date

Type

Title

01/06/2024

PubMed

 Impact of prior use of antiplatelets on COVID-19 susceptibility, progression, and severity: a population-based study.

09/08/2023

News Article

 Global Robot Controllers Market Size [2030]

05/01/2023

PubMed

 In silico identification of molecular mechanisms for stroke risk caused by heavy metals and their mixtures: Sponges and drugs involved.

10/08/2021

News Article

 Worldwide Triflusal Industry to 2026 - by Manufacturers, Regions, Technology, Application and Product Type

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions